Product Information:
FORMIGET 400/12 mcg Capsules contain a fixed-dose combination of:
- Budesonide 400 mcg – an inhaled corticosteroid (ICS) that reduces airway inflammation
- Formoterol Fumarate 12 mcg – a long-acting beta₂-adrenergic agonist (LABA) that provides sustained bronchodilation
This high-strength formulation is intended for the maintenance treatment of moderate to severe asthma and chronic obstructive pulmonary disease (COPD) in adults and adolescents. The capsules are designed for use with a compatible dry powder inhaler (DPI) device and are for oral inhalation only—not for oral ingestion.
Uses of (FORMIGET 400/12 MCG CAPSULES):
- Maintenance therapy in severe persistent asthma not controlled with lower ICS/LABA doses
- Management of moderate to severe COPD with frequent exacerbations
- Patients requiring intensified anti-inflammatory and bronchodilator therapy
- Step-up treatment when symptoms persist despite standard-dose combination therapy
Key Benefits of (FORMIGET 400/12 MCG CAPSULES):
- Enhanced anti-inflammatory effect (higher budesonide dose)
- Potent and rapid bronchodilation (formoterol acts within 1–3 minutes, lasts up to 12 hours)
- Reduces risk of severe exacerbations and hospitalizations
- Improves lung function, exercise tolerance, and quality of life
- Once- or twice-daily dosing for convenience
How To Use (FORMIGET 400/12 MCG CAPSULES):
- For inhalation only using a compatible dry powder inhaler (e.g., Turbuhaler-type device).
- Do not swallow the capsule.
- Typical dosage:
- Asthma: 1 capsule twice daily (morning and evening)
- COPD: 1 capsule twice daily
- Insert capsule into the inhaler, pierce it, and inhale deeply and forcefully through the mouthpiece.
- Rinse mouth thoroughly with water after each use to prevent oral thrush and hoarseness.
When Not to Use (FORMIGET 400/12 MCG CAPSULES):
Do not use if you have:
- Hypersensitivity to budesonide, formoterol, or any excipients
- Acute asthma attack, status asthmaticus, or acute bronchospasm (not a rescue medication)
- Severe milk protein allergy (some DPI devices contain lactose)
- Uncontrolled cardiac arrhythmias or severe cardiovascular disease (use with extreme caution)
Side Effects of (FORMIGET 400/12 MCG CAPSULES):
Common: Headache, tremor, palpitations, throat irritation, hoarseness, oral candidiasis (thrush), cough.
Rare: Tachycardia, muscle cramps, hypokalemia, adrenal suppression (with prolonged high-dose use).
Serious (rare):
- Paradoxical bronchospasm (worsening breathing after use)
- Pneumonia (especially in COPD patients—symptoms: fever, increased sputum, chest pain)
- Glaucoma, cataracts, or reduced bone mineral density with long-term use
- Discontinue and seek immediate help if breathing worsens suddenly after inhalation.
Dosage: (FORMIGET 400/12 MCG CAPSULES):
- Adults & adolescents (≥12 years): 1 capsule twice daily
- Maximum: 2 capsules per day (do not exceed)
- Not for children under 12 years
- LABAs must always be used with an ICS—never as monotherapy in asthma
Who It’s For (FORMIGET 400/12 MCG CAPSULES):
Adults and adolescents with severe asthma or advanced COPD requiring high-dose maintenance therapy. Not for mild disease, intermittent symptoms, or acute attacks.
Warnings & Precautions:
- Not a rescue inhaler—use short-acting beta-agonists (e.g., salbutamol) for acute symptoms
- Monitor COPD patients for pneumonia
- Long-term high-dose ICS may suppress adrenal function or affect growth in adolescents
- Avoid abrupt discontinuation—taper under medical supervision
- Inform surgeon/dentist before procedures (adrenal suppression risk)
Drug Interactions:
- Beta-blockers: May block bronchodilator effect and provoke bronchospasm
- Diuretics, theophylline: Increased risk of hypokalemia
- Strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir): May increase budesonide levels
- Always inform your doctor about all medications.
Additional Information:
Store below 30°C in a dry place, protected from light and moisture. Keep capsules in original blister until use. Discard unused capsules after opening the blister. Available by prescription in Pakistan.